1. Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer: A Brown University Oncology Research Group Phase II Study (BrUOG295). (December 2020) Authors: Raufi, Alexander G.; Breakstone, Rimini; Leonard, Kara; Charpentier, Kevin; Beard, Rachel; Renaud, Jennifer; Cavanaugh, Lindsey; Sturtevant, Ashlee; MacKinnon, Kelsey; Almhanna, Khaldoun; Olszewski, Adam; Safran, Howard P. Journal: American journal of clinical oncology Issue: Volume 43:Number 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial. (February 2021) Authors: Elinzano, Heinrich; Toms, Steven; Robison, Jordan; Mohler, Alex; Carcieri, Arieana; Cielo, Deus; Donnelly, Jennifer; Disano, Dylan; Vatketich, John; Baekey, John; Sturtevant, Ashlee; MacKinnon, Kelsey; Wood, Roxanne; Safran, Howard Journal: American journal of clinical oncology Issue: Volume 44:Number 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗